Perspectives on RNA Sequencing: Deeper Insights

1 July 2016

Matt Thomas, a research associate studying host-viral pathogen responses through RNA-seq is fascinated by the high-throughput and simplified workflow of Illumina next-generation sequencing systems. RNA sequencing provides deeper insights for the complex research they perform using small RNA, and RIP seq, moving beyond just gene expression. The quick turnaround combined with the flexibility of short and long reads on the NextSeq 500 is a real asset to their cutting-edge work in virology. Video Presenter: Matt Thomas, Research Manager University of Washington Subscribe to the Illumina video channel. http://www.youtube.com/subscription_center?add_user=IlluminaInc

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.